**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 394-25-2 |4-Methoxy-3-Nitrobenzotrifluoride | 99 | 206-891-4 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: C
Risk Phrases: 34
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Causes burns.Corrosive.
Potential Health Effects
Eye:
Causes eye burns. May cause chemical conjunctivitis and corneal
damage.
Skin:
Causes skin burns. May cause skin rash (in milder cases), and cold
and clammy skin with cyanosis or pale color.
Ingestion:
May cause severe and permanent damage to the digestive tract. Causes
gastrointestinal tract burns. May cause perforation of the digestive
tract. Ingestion of large amounts of fluoride may cause salivation,
nausea, vomiting, abdominal pain, fever, labored breathing. Exposure
to fluoride compounds can result in systemic toxic effects on the
heart, liver, and kidneys. It may also deplete calcium levels in the
body leading to hypocalcemia and death. Contains fluoride. Fluoride
can reduce calcium levels leading to fatal hypocalcemia. May cause
systemic effects.
Inhalation:
May cause severe irritation of the respiratory tract with sore
throat, coughing, shortness of breath and delayed lung edema. Causes
chemical burns to the respiratory tract. The toxicological
properties of this substance have not been fully investigated.
Aspiration may lead to pulmonary edema. May cause systemic effects.
Chronic:
Chronic inhalation and ingestion may cause chronic fluoride
poisoning (fluorosis) characterized by weight loss, weakness,
anemia, brittle bones, and stiff joints. Effects may be delayed.
Chronic exposure to fluoride compounds may cause systemic toxicity.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Get medical aid. Do NOT allow victim to rub eyes or keep eyes
closed. Extensive irrigation with water is required (at least 30
minutes).
Skin:
Get medical aid immediately. Immediately flush skin with plenty of
water for at least 15 minutes while removing contaminated clothing
and shoes. Wash clothing before reuse. Destroy contaminated shoes.
Ingestion:
Get medical aid. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh
air immediately. If not breathing, give artificial respiration. If
breathing is difficult, give oxygen. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use agent most appropriate to extinguish fire. Use water spray, dry
chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Remove all sources of ignition. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation. Discard contaminated shoes.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances. Corrosives
area.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 394-25-2:
United States OSHA: 2.5 mg/m3 TWA (as F) (listed under Fluorides
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Crystals
Color: yellow crystalline powder
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 153 deg C @ 28mmHg
Freezing/Melting Point: 47.00 - 49.00 deg C
Autoignition Temperature: Not applicable.
Flash Point: > 110 deg C (> 230.00 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H6F3NO3
Molecular Weight: 221.14
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, irritating and toxic fumes and
gases, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 394-25-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Methoxy-3-Nitrobenzotrifluoride -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: CORROSIVE LIQUID, N.O.S.*
Hazard Class: 8
UN Number: 1760
Packing Group: II
IMO
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing Group: II
RID/ADR
Shipping Name: CORROSIVE LIQUID, N.O.S.
Hazard Class: 8
UN Number: 1760
Packing group: II
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: C
Risk Phrases:
R 34 Causes burns.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 394-25-2: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 394-25-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 394-25-2 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 7/15/1999 Revision #2 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methacrylonitrile, 99% (stabilized with 50 ppm MEHQ)
| 126-98-7 |
|
Boron Trifluoride Dimethanol Complex (50-52 wt% BF3)
| 67-56-1 |
|
Dimethylsulfamoyl Chloride, 99% (GC)
| 13360-57-1 |
|
2,4-Dichloroanisole, 99+%
| 553-82-2 |
|
2-Fluorobenzaldehyde, 97%
| 446-52-6 |
|
Benzoylacetonitrile
| 614-16-4 |
|
3-Fluorobenzonitrile, 98%
| 403-54-3 |
|
3,3,5-Trimethylcyclohexanone, 97%
| 873-94-9 |
|
cis-4-Decenal, 98%
| 21662-09-9 |
|
Cyclohexyl bromide, 99%
| 108-85-0 |
|
Alpha, Alpha, Alpha,4-Tetrafluoro-O-Toluidine, 99%
| 393-39-5 |
|
4-Methoxy-3-Nitrobenzotrifluoride, 99%
| 394-25-2 |
|
Isatoic Anhydride, 98% (Titr.)
| 118-48-9 |
|
2,4'-Difluorobenzophenone, 98%
| 342-25-6 |
|
5-Chloro-2-(Methylamino)benzophenone, 99%
| 1022-13-5 |
|
Hydroquinone sulfonic acid, potassium salt tech.
| 21799-87-1 |
|
L-Leucyl-L-Alanine, Hydrate
| 7298-84-2 |
|
Trifluoroacetaldehyde ethyl hemiacetal, 90%
| 433-27-2 |
|
4-Sulfonic Calix[4]Arene Hydrate, 95%
| 0-01-1 |
|
(n-Propyl)triphenylphosphonium bromide, 99%
| 15912-75-1 |
|
5-Nitro-2-Furaldehyde Diacetate, 98%
| 92-55-7 |
|
3-Nitro-L-Tyrosine, 99%
| 621-44-3 |
|
2-(3-Methoxyphenyl)Cyclohexanone
| 15547-89-4 |
|
2,2'-Dihydroxy-4,4'-dimethoxybenzophenone, 98%
| 131-54-4 |
|
Hippuric Acid, 98%
| 495-69-2 |
|
Dibutyl oxalate, 99%
| 2050-60-4 |
|
N-(2-Hydroxyethyl)Morpholine, 99%
| 622-40-2 |
|
4-Methoxybenzamide (P-Anisamide), 97%
| 3424-93-9 |
|
Manganese(III) acetate dihydrate, 98%
| 993-02-2 |
|
Hexaketocyclohexane octahydrate, 97%
| 527-31-1 |
|
Prussian blue
| 14038-43-8 |
|
(S)-2-Amino-3-Methoxypropanoic Acid Hydrochloride, 98%
| 0-00-1 |
|
trans-1,2-Dichloroethylene, 99.7%, stabilized with 950 ppm BLO and
| 156-60-5 |
|
5-Bromovaleric acid, 97%
| 2067-33-6 |
|
gamma-Decalactone, 97%
| 706-14-9 |
|
Indophenol blue, 99% (uv-vis)
| 132-31-0 |
|
TETRAACETYLETHYLENEDIAMINE, 99.5+%
| 10543-57-4 |
|
Cis-2-Aminocyclohexanol Hydrochloride, 99+%
| 6936-47-6 |
|
5-Chloro-1-phenyl-1h-tetrazole, 97%
| 14210-25-4 |
|
3-Hydroxy-3-methyl-2-butanone, 92%
| 115-22-0 |
|
Precocene I, 99%
| 17598-02-6 |
|
1,3-Dichloroacetone, 99%
| 534-07-6 |
|
2,3-Pyrazinedicarboxamide, 97%
| 6164-78-9 |
|
4-Bromobenzoic Acid 97%
| 586-76-5 |
|
Molecular Sieves, 3A, 4 to 8 Mesh
| 0-00-1 |
|
M-(p-tert-butylphenoxy)benzaldehyde, 99%
| 69770-23-6 |
|
Lysergol
| 602-85-7 |
|
Poly(Vinyl Methyl Ketone) Average M.W. 500.000
| 25038-87-3 |
|
Adenine Sulfate, Dihydrate, 98% (Titr.)
| 321-30-2 |
|
2-(4-Aminophenyl)ethylamine, 95%
| 13472-00-9 |
|
|